Low impact
GSK and Hansoh Pharmaceutical's experimental drug helped small-cell lung cancer patients in a late-stage Chinese trial live longer.
bloomberg-industries07/10, 06:49 PM
Related assets
Coming up for GSK
Explore next
Latest GSK news
WSJ07/29, 07:12 PM
WSJ Markets publishes a Health Care Market Talk roundup covering Argenx, GSK, and EssilorLuxottica.
WSJ07/17, 11:43 PM
FirstSquawk07/17, 03:33 PM